Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2014, Article ID 406242, 7 pages
http://dx.doi.org/10.1155/2014/406242
Research Article

Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera

1Molecular Cancer Biology Research Group, Molecular Pathology and Immunology Division, Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University, Nigeria
2Cancer Research Unit, Saskatchewan Cancer Agency, Room A 231, Health Science Building, University of Saskatchewan, Saskatoon, SK, Canada S7N 5R5
3Department of Pathology and Molecular Medicine and Department of Cell Physiology and Pharmacology, University of Leicester, UK

Received 24 July 2014; Revised 12 November 2014; Accepted 18 November 2014; Published 8 December 2014

Academic Editor: Margaret James

Copyright © 2014 Maxwell Omabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. V. Costa-Lotufo, M. T. H. Khan, A. Ather et al., “Studies of the anticancer potential of plants used in Bangladeshi folk medicine,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 21–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sreelatha and P. R. Padma, “Modulatory effects of Moringa oleifera extracts against hydrogen peroxide-induced cytotoxicity and oxidative damage,” Human and Experimental Toxicology, vol. 30, no. 9, pp. 1359–1368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Abd El Latif, S. El Bialy Bel, H. D. Mahboub, and M. A. Abd Eldaim, “Moringa oleifera leaf extract ameliorates alloxan-induced diabetes in rats by regeneration of β cells and reduction of pyruvate carboxylase expression,” Biochemistry and Cell Biology, vol. 92, no. 5, pp. 413–419, 2014. View at Google Scholar
  4. C. Gupta and D. Prakash, “Phytonutrients as therapeutic agents,” Journal of Complementary and Integrative Medicine, vol. 11, no. 3, pp. 151–169, 2014. View at Google Scholar
  5. C. Horiakwa, Y. Yoshimura, C. Kamada et al., “Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes—analysis of the Japan diabetes complications study (JDCS),” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 10, pp. 3635–3643, 2014. View at Publisher · View at Google Scholar
  6. C. Anholm, P. Kumarathurai, M. S. Klit et al., “Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol,” BMJ Open, vol. 4, no. 7, Article ID e005942, 2014. View at Google Scholar
  7. J. S. Mossa, “A study on the crude antidiabetic drugs used in Arabian folk medicine,” Pharmaceutical Biology, vol. 23, no. 3, pp. 137–145, 1985. View at Google Scholar · View at Scopus
  8. D. Q. Holland and J. J. Neumiller, “Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus,” Journal of Diabetes, Metabolic Syndrome and Obesity, vol. 7, pp. 277–288, 2014. View at Google Scholar
  9. B. Moyo, S. Oyedemi, P. J. Masika, and V. Muchenje, “Polyphenolic content and antioxidant properties of Moringa oleifera leaf extracts and enzymatic activity of liver from goats supplemented with Moringa oleifera leaves/sunflower seed cake,” Meat Science, vol. 91, no. 4, pp. 441–447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hussain, F. Malik, and S. Mahmood, “Review: an exposition of medicinal preponderance of Moringa oleifera (Lank.),” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 2, pp. 397–403, 2014. View at Google Scholar · View at Scopus
  11. S. Wadhwa, M. S. Panwar, N. Saini, S. Rawat, and S. Singhal, “A review on commercial, traditional uses phytoconstituents and pharmacological activity of Moringa Oleifera,” Global Journal of Traditional Medicinal Systems, vol. 2, no. 1, pp. 1–13, 2013. View at Google Scholar
  12. F. Anwar, S. Latif, M. Ashraf, and A. H. Gilani, “Moringa oleifera: a food plant with multiple medicinal uses,” Phytotherapy Research, vol. 21, no. 1, pp. 17–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Jaiswal, P. Kumar Rai, A. Kumar, S. Mehta, and G. Watal, “Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 392–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. B. Subudhi and A. Bhoi, “Antioxidative effects of Brassica juncea and Moringa oliefera prepared by different processing methods,” Journal of Food Science and Technology, vol. 51, no. 4, pp. 790–794, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Verma, M. Vijayakumar, C. S. Mathela, and C. V. Rao, “In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves,” Food and Chemical Toxicology, vol. 47, no. 9, pp. 2196–2201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Workman, E. O. Aboagye, F. Balkwill et al., “Guidelines for the welfare and use of animals in cancer research,” British Journal of Cancer, vol. 102, no. 11, pp. 1555–1577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Gylfe and P. Gilon, “Glucose regulation of glucagon secretion,” Diabetes Research and Clinical Practice, vol. 103, no. 1, pp. 1–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. Owens, L. Monnier, and G. B. Bolli, “Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus,” Diabetes and Metabolism, vol. 39, no. 6, pp. 485–496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. G. Jain, S. D. Patil, N. G. Haswani, M. V. Girase, and S. J. Surana, “Hypolipidemic activity of Moringa oleifera Lam., Moringa ceae, on high fat diet induced hyperlipidemia in albino rats,” Brazilian Journal of Pharmacognosy, vol. 20, no. 6, pp. 969–973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Sangkitikomol, A. Rocejanasaroj, and T. Tencomnao, “Effect of Moringa oleifera on advanced glycation end-product formation and lipid metabolism gene expression in HepG2 cells,” Genetics and Molecular Research, vol. 13, no. 1, pp. 723–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. H. D. Yassa and A. F. Tohamy, “Extract of Moringa oleifera leaves ameliorates streptozotocin-induced diabetes mellitus in adult rats,” Acta Histochemica, vol. 116, no. 5, pp. 844–854, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  23. K. Carolo Dos Santos, C. Pereira Braga, P. Octavio Barbanera, F. Rodrigues Ferreira Seiva, A. Fernandes Junior, and A. A. Fernandes, “Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol,” PLoS ONE, vol. 9, no. 7, Article ID e102775, 2014. View at Google Scholar
  24. G. A. Asare, K. Bugyei, A. Sittie et al., “Genotoxicity, cytotoxicity and toxicological evaluation of whole plant extracts of the medicinal plant Phyllanthus niruri (Phyllanthaceae),” Genetics and Molecular Research, vol. 11, no. 1, pp. 100–111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. A. Asare, B. Gyan, K. Bugyei et al., “Toxicity potentials of the nutraceutical Moringa oleifera at supra-supplementation levels,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 265–272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Nandave, S. K. Ojha, S. Joshi, S. Kumari, and D. S. Arya, “Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: Evidence for an antioxidant, antiperoxidative, and cardioprotective intervention,” Journal of Medicinal Food, vol. 12, no. 1, pp. 47–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Hsiao, T. Y. Chen, C. C. Chiu et al., “Delayed high anion gap metabolic acidosis after a suicide attempt: case report,” Clinica Chimica Acta, vol. 436, pp. 329–331, 2014. View at Publisher · View at Google Scholar
  28. B. Bostrom, P. Uppal, J. Chu, Y. Messinger, L. Gandrud, and R. McEvoy, “Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia,” Journal of Pediatric Hematology/Oncology, vol. 35, no. 7, pp. 504–508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Biradar, J. L. Moran, S. L. Peake, and J. V. Peter, “Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit,” Critical Care and Resuscitation, vol. 12, no. 3, pp. 191–195, 2010. View at Google Scholar
  30. C.-T. Chang, Y.-C. Chen, J.-T. Fang, and C.-C. Huang, “High anion gap metabolic acidosis in suicide: don't forget metformin intoxication—two patients' experiences,” Renal Failure, vol. 24, no. 5, pp. 671–675, 2002. View at Publisher · View at Google Scholar · View at Scopus